Despite their shared origin, Melanotan II and PT-141 differ significantly in their receptor selectivity, physiological effects, intended research focus, and safety considerations
If your healthcare provider agrees that the switch is appropriate, their priority will be your safety, so that each case might be slightly different
For women of childbearing potential, these medications are not recommended during pregnancy or breastfeeding, and discontinuation is advised at least 2 months before planned pregnancy for semaglutide and 1 month for tirzepatide
"This evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long term weight control," the researchers write
Your obstetrician decides if, when and how it is given
Thats where supplement injections can really make a huge difference